InvestorsHub Logo
Followers 0
Posts 178
Boards Moderated 0
Alias Born 12/04/2013

Re: None

Monday, 10/29/2018 11:47:02 AM

Monday, October 29, 2018 11:47:02 AM

Post# of 8435
So why were the PEG/GEM/AB PFS figures announced at ESMO 2018 way lower than in the 201 trial? The market clearly thinks this is a sign that the 301 trial results will be poor too. If they can’t beat 8.5 months then they might as well shelve it for PC. Maybe the addition of new patients is in the hope that the OS figures are better than anticipated and the only way of coming up with the OS results at the same time as announcing the PFS results is to increase the trial size and buy more time.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News